Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1966 10
1967 8
1968 7
1969 7
1970 5
1971 3
1972 4
1973 10
1974 3
1975 7
1976 7
1977 7
1978 8
1979 7
1980 12
1981 4
1982 9
1983 7
1984 3
1985 3
1986 13
1987 9
1988 17
1989 14
1990 22
1991 26
1992 30
1993 28
1994 28
1995 31
1996 40
1997 39
1998 25
1999 48
2000 43
2001 27
2002 15
2003 26
2004 28
2005 36
2006 48
2007 41
2008 36
2009 47
2010 60
2011 81
2012 74
2013 73
2014 53
2015 65
2016 61
2017 74
2018 62
2019 63
2020 59
2021 64
2022 65
2023 34
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,626 results

Results by year

Filters applied: . Clear all
Page 1
Influenza Vaccine.
Walter K. Walter K. JAMA. 2020 Oct 13;324(14):1476. doi: 10.1001/jama.2020.16846. JAMA. 2020. PMID: 32857125 No abstract available.
Vaccine-Preventable Diseases in Older Adults.
Al-Jabri M, Rosero C, Saade EA. Al-Jabri M, et al. Infect Dis Clin North Am. 2023 Mar;37(1):103-121. doi: 10.1016/j.idc.2022.11.005. Infect Dis Clin North Am. 2023. PMID: 36805008 Review.
Influenza vaccines: Evaluation of the safety profile.
Trombetta CM, Gianchecchi E, Montomoli E. Trombetta CM, et al. Hum Vaccin Immunother. 2018 Mar 4;14(3):657-670. doi: 10.1080/21645515.2017.1423153. Epub 2018 Jan 30. Hum Vaccin Immunother. 2018. PMID: 29297746 Free PMC article. Review.
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial.
Nguyen TT, Chiu CH, Lin CY, Chiu NC, Chen PY, Le TTV, Le DN, Duong AH, Nguyen VL, Huynh TN, Truong HK, Phan TL, Nguyen TTT, Shih SR, Huang CG, Weng YJ, Hsieh EF, Chang S, Chen C, Tai IC, Huang LM. Nguyen TT, et al. Lancet. 2022 Apr 30;399(10336):1708-1717. doi: 10.1016/S0140-6736(22)00313-0. Epub 2022 Apr 12. Lancet. 2022. PMID: 35427481 Clinical Trial.
Reduced-dose influenza vaccine.
Wyatt KN, Ryan GJ, Sheerin KA. Wyatt KN, et al. Ann Pharmacother. 2006 Sep;40(9):1635-9. doi: 10.1345/aph.1G645. Epub 2006 Jul 11. Ann Pharmacother. 2006. PMID: 16835314 Review.
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis.
Lee IT, Nachbagauer R, Ensz D, Schwartz H, Carmona L, Schaefers K, Avanesov A, Stadlbauer D, Henry C, Chen R, Huang W, Schrempp DR, Ananworanich J, Paris R. Lee IT, et al. Nat Commun. 2023 Jun 19;14(1):3631. doi: 10.1038/s41467-023-39376-7. Nat Commun. 2023. PMID: 37336877 Free PMC article. Clinical Trial.
1,626 results